Nissan to cut Rogue SUV production in Japan amid Nexperia chip shortage – Reuters
Nissan to cut Rogue SUV production in Japan amid Nexperia chip shortage – Reuters
Source link
Similar Posts
Consolidated Construction Shares Skyrocket 19% on Rs 180 Crore Order
September 12, 2025September 12, 2025 Shares of Consolidated Construction Consortium Ltd (CCCL) skyrocketed 19% on 12 September after the company announced securing multiple orders from diverse clients under its buildings and factories (B&F) business vertical. CCCL has secured new projects worth Rs 180 crore, covering…
Why does your portfolio bleed when global markets fall!
Imagine when you open your portfolio and see red colour all over your portfolio. There is no negative news regarding the assets you own, no disappointing earnings and no sudden policy shock in India. Yet, your investments are on the decline. For many investors, this is a confusing and frustrating situation. The reality is that…
3 Cr means Value Luxury
Source : Earnings call of Suraj Estates Ltd Oplus_131072 Source link
Vedanta Shares Fall as Boiler Blast Probe Flags Negligence
April 17, 2026April 17, 2026 Shares of Vedanta Limited fell on 17 April after a preliminary technical probe into the deadly boiler blast at its Chhattisgarh power plant flagged fuel accumulation, pressure build-up and alleged maintenance lapses, with the stock sliding to an intraday low before trimming losses through…
Trading Watch List 06.20.2024
QQQ indecision day after extended run. Given the frothiness of big tech , it wouldn’t be surprising to see a pull soon.A pull would be nice to set some charts again. Follow me on X/Twitter for real time trading setups @szaman and on StockTwits @szaman. Watch us trade these stocks LIVE, in real-time. Click here to…
Vantagepoint Stock of the Week BioNTech SE ($BNTX)
This Week’s a.i. Stock Spotlight is BioNTech SE ($BNTX) BioNTech SE ($BNTX) is a German biotechnology company focused on developing and manufacturing advanced immunotherapies for cancer and infectious diseases. The company gained global recognition for co-developing one of the first mRNA-based COVID-19 vaccines, known as Comirnaty, in partnership with Pfizer. BioNTech’s primary focus is on…
